Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeEAM conditioning before autologous transplantation for lymphoma
ChiCTR2100048232Phase 4Not yet recruiting
- Sponsor
- Henan Provincial People's Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bendamustine, etoposide, cytarabine and melphalan in lymphoma, sponsored by Henan Provincial People's Hospital. Primary endpoints: 2-year progression-free survival and Complete response rate. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
bendamustineetoposidecytarabinemelphalan
03
Conditions
lymphoma
Beyond the preview
Go deeper on ChiCTR2100048232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048232.